Skip to content
akaturk Academic measurement

Article detail · 2023

Impact of Valproate and Levetiracetam Exposure on GAERS Behavior During Pregnancy

Archives of epilepsy (Online)

YÖKSİS OpenAlex Open access · diamond SJR Q4 JCR Q4 TR Index Citations 1 Percentile 70.1% FWCI 0.5
Year
2023
ISSN
2792-0550
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

Objective: Valproate (VPA) and levetiracetam (LEV) are frequently prescribed for the management of idiopathic generalized seizures; however, their welldocumented teratogenic effects raise concerns when administered to pregnant epileptic patients.This study aimed to assess the impact of VPA and LEV exposure during pregnancy on Genetic Absence Epilepsy Rats from Strasbourg (GAERS).Methods: Female GAERS rats were categorized into three groups: saline-treated (n=6), VPA-treated (200 mg/kg, n=4), and LEV-treated (50 mg/kg, n=6).Intraperitoneal injections were initiated from mating start and continued until partition.Locomotor activity and anxiety-like behavior were evaluated using openfield and hole-board tests for the VPA-treated and VPA-and LEV-treated groups; respectively.These tests were conducted both before and during pregnancy.Results: Across all groups, open-field testing demonstrated a tendency toward reduced locomotor activity parameters compared with pre-pregnancy, with VPA treatment showing significance (p<0.05).The hole-board test indicated a trend toward decreased rearing and hole exploration, coupled with increased freezing behavior in the saline-and VPA-treated groups.The LEV-treated group showed an elevation in freezing behavior and a decline in hole exploration.Conclusion: Although minimal effects on anxiety-like behaviors were noted in anti-seizure drug-treated rats, subtle tendencies were evident in the holeboard test.VPA and LEV administration resulted in depressive parameters in the locomotor activity test.These findings emphasize the need for caution when prescribing and using VPA and the LEV during pregnancy in terms of maternal behavior and mood.

Topics

  • Pharmacological Effects and Toxicity Studies
  • Pregnancy and Medication Impact
  • Maternal Mental Health During Pregnancy and Postpartum

Primary topic Pharmacological Effects and Toxicity Studies

Authors

  1. MELİS YAVUZ ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ
  2. Berk Can Kantarcı
  3. AHMET ŞANLI
  4. ŞEYHMUS GAVAŞ
  5. ZEHRA NUR TURGAN AŞIK
  6. TÜRKAN KOYUNCUOĞLU İSTANBUL AREL ÜNİVERSİTESİ
  7. ÖZGÜR KASIMAY BERKÖZ
  8. FİLİZ ONAT ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ